Coghill AE, Johnson LG, Berg D, Resler AJ, Leca N, Madeleine MM
Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: pooled analysis of the SUSTAIN 1-5 trials
While its weight loss efficacy may be less pronounced compared to GLP-1, Ozempic, and Wegovy, Trulicity still offers meaningful benefits in terms of weight reduction and glycemic control
It is now even more important that treatments for type 2 diabetes should be selected not just solely on their glucose lowering capability but also on their overall ability to lower mortality
They were never meant to be used for a small amount of weight loss in a person who is metabolically healthy, she says
doi: 10.1186/1471-2202-9-1 45 NakaoYTatenoKOhtuboY